Abivax (ABVX) Other Non-Current Liabilities (2024 - 2026)

Abivax's Other Non-Current Liabilities history runs 3 years deep, the most recent figure standing at $26.0 million for Q1 2026.

• In Q1 2026, Other Non-Current Liabilities changed N/A year-over-year to $26.0 million; the TTM figure through Mar 2026 stood at $26.0 million (changed N/A YoY), while the FY2025 annual figure was $41.1 million, up 2303.31% from the prior year.
• Other Non-Current Liabilities was $26.0 million for Q1 2026 at Abivax, down from $41.1 million in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $41.1 million in Q4 2025 to a low of $1.7 million in Q4 2024.
• Historically, Other Non-Current Liabilities has averaged $22.9 million across 3 years, with a median of $26.0 million in 2026.
• Biggest YoY gain for Other Non-Current Liabilities was 2303.31% in 2025; the steepest drop was 2303.31% in 2025.
• A 3-year view of Other Non-Current Liabilities shows it stood at $1.7 million in 2024, then surged by 2303.31% to $41.1 million in 2025, then slumped by 36.75% to $26.0 million in 2026.
• The last three Other Non-Current Liabilities figures came in at $26.0 million (Q1 2026), $41.1 million (Q4 2025), and $1.7 million (Q4 2024), per Business Quant data.